Build status - In Progress

Prospective US Radiofrequency SUI Trial (PURSUIT)

Prospective US Radiofrequency SUI Trial (PURSUIT)
Recruiting
18 years - 99 years
Female
Phase N/A
14 participants needed
1 Location

Brief description of study

PURSUIT: Prospective US Radiofrequency SUI Trial (VI-17-06) is a prospective, randomized, sham controlled, double blind study in premenopausal women with stress urinary incontinence. The primary objective is to evaluate the efficacy of the Viveve treatment, SUI protocol, in improving mild to moderate stress urinary incontinence (SUI), assessed using the 1-hour Pad Weight Test for up to 12 months post-treatment.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Urinary Incontinence,Stress
  • Age: 18 years - 99 years
  • Gender: Female

Female, Age 18 or older Diagnosis of stress urinary incontinence

Updated on 04 Aug 2024. Study ID: 848695

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center